abstract |
The present invention relates to new derivatives of 2-piperazin-1-yl-4H-1,3-benzothiazin-4-one and their use for the treatment of infections in mammals caused by bacteria, in particular diseases such as tuberculosis (TB), Buruli ulcer and leprosy, which result from infection with closely related mycobacteria. |